The Precision Peptide Company Inc. Logo

The Precision Peptide Company Inc. (PNGAF)

OTC

Currency in USD
0.3155
-0.0054 (-1.67%)

Closed

Aug 21, 2026

Day's Range

0.3155
0.3400

52 wk Range

0.1000
0.5000

Overview - PNGAF - The Precision Peptide Company Inc.

Key Statistics

Valuation

Enterprise Value

10.26M

P/E (Trailing)

‪-1.52‬

PEG Ratio

‪0.02‬

Price / Sales (TTM)

‪136.53‬

Price / Book

‪19.26‬

EV / EBITDA

‪-3.95‬

Profitability

Gross Margin

‪-1.68%‬

Profit Margin

‪44.14%‬

Operating Margin

‪-2,921.65%‬

Return on Assets

‪-115.10%‬

Return on Equity

‪-391.66%‬

Ownership

Shares Outstanding

45.71M

Float

45.89M

Held by Insiders

‪2.54%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪0.18‬

50-Day Avg

‪0.3368‬

200-Day Avg

‪0.2768‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 17, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - PNGAF - The Precision Peptide Company Inc.

Peers - PNGAF - The Precision Peptide Company Inc.

Peer Comparison

Compared with companies in Packaged Foods listed on OTC.

Profile Summary - PNGAF - The Precision Peptide Company Inc.

About

The Precision Peptide Company Inc. is a biotechnology firm specializing in the development and production of high-purity peptides for therapeutic and research applications. The company synthesizes custom peptides tailored for medical treatments, pharmaceutical research, and clinical studies, with a focus on areas…

SectorConsumer Defensive
IndustryPackaged Foods
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.